New York, New York--(Newsfile Corp. - November 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.SO WHAT: If you purchased agilon health securities you may be entitled to compensation without payment of any out of pocket fees or costs through a c ...

Too many investors give short shrift to utility stocks, deeming the sector to be drab and dour, with the main draw a nice dividend return.Not anymore, as burgeoning technology demands are providing a powerful jolt to the utility realm. A case in point: So far in 2025, the utilities sector has quietly outpaced much of Big Tech, riding a wave of investor enthusiasm tied to the energy needs of artificial intelligence. The Utilities Select Sector SPDR Fund (NYSE:XLU) is up 23.4% year-to-date, well ahead of the ...

RB Global, Inc. (NYSE:RBA) reported upbeat earnings for the third quarter on Thursday.The company posted quarterly earnings of 93 cents per share which beat the analyst consensus estimate of 82 cents per share. The company reported quarterly sales of $1.093 billion which beat the analyst consensus estimate of $1.054 billion.“GTV growth this quarter was broad-based across every sector, reflecting the dedication of our teammates and our commitment to being trusted partners,” said Jim Kessler, CEO of RB Global ...

An updated edition of the September 16, 2025, article.Founders possess a rare ability to shape and nurture their companies from inception, much like a parent raising a child. With a clear vision and unwavering commitment, they guide their ventures through uncertainty, often taking risks and pursuing unconventional ideas that traditional managers might avoid. Founder-led businesses typically reflect the personal values, ideals, and long-term aspirations of their creators, serving as enduring manifestations o ...

Key Takeaways Denali posted a Q3 loss of $0.74 per share, wider than last year's $0.63 loss. FDA extended tividenofusp alfa's approval decision to April 2026 after a major amendment.DNLI advanced programs for Sanfilippo, Alzheimer, Parkinson and Pompe diseases.Denali Therapeutics (DNLI) reported a third-quarter 2025 loss of 74 cents per share, narrower than the Zacks Consensus Estimate of a loss of 76 cents. The company reported a loss of 63 cents in the year-ago quarter.The loss per share widened year over ...

核心事件 - 罗森律师事务所正在代表Zions Bancorporation N A (NASDAQ: ZION) (NASDAQ: ZIONP)的股东调查潜在的证券索赔 指控该公司可能向投资公众发布了具有重大误导性的商业信息 [1] - 调查起因是Zions Bancorporation于2025年10月15日宣布 因其全资子公司California Bank & Trust承销的一笔贷款出现“明显的借款人和义务人虚假陈述、合同违约以及其他与贷款和抵押品相关的不规范行为” 公司将计提5000万美元的坏账冲销 [3] - 在此消息公布后 Zions Bancorporation的普通股股价于2025年10月16日下跌了13.14% [4] 公司应对措施 - Zions Bancorporation披露将聘请律师协调对此事进行独立审查 [3] - 罗森律师事务所正在准备集体诉讼 旨在为投资者挽回损失 [2]

HOLMDEL, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will host its third quarter investor call on Friday, November 14th at 10 a.m. ET. Results will be released before the market opens that morning. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and host a Q&A session. Call DetailsDate / Time:Friday, November 14th at 10 a.m. ETCall Di ...

Five9 (NASDAQ:FIVN) reported better-than-expected earnings for the third quarter on Thursday.The company posted quarterly earnings of 78 cents per share which beat the analyst consensus estimate of 73 cents per share. The company reported quarterly sales of $285.800 million which beat the analyst consensus estimate of $285.042 million.Five9 raised its FY2025 adjusted EPS guidance from $2.86-$2.90 to $2.92-$2.96 and cut its sales guidance from $1.144 billion-$1.150 billion to $1.143 billion-$1.149 billion.“W ...

Five9 (NASDAQ:FIVN) reported better-than-expected earnings for the third quarter on Thursday.The company posted quarterly earnings of 78 cents per share which beat the analyst consensus estimate of 73 cents per share. The company reported quarterly sales of $285.800 million which beat the analyst consensus estimate of $285.042 million.Five9 raised its FY2025 adjusted EPS guidance from $2.86-$2.90 to $2.92-$2.96 and cut its sales guidance from $1.144 billion-$1.150 billion to $1.143 billion-$1.149 billion.“W ...

Buy now, pay later companies like Affirm are aiming to compete more closely with credit-card companies. ...